Discovery shows statins could fight cancerSeptember 14th, 2012 - 5:03 pm ICT by IANS
Washington, Sep 14 (IANS) A new discovery linking cholesterol with cancer shows how cholesterol busting drugs, or statins, can prevent cancer or supplement its existing treatments.
The discovery was made by University of Rochester Medical Centre. It validates the theory that people with highest levels of cholesterol seem to have higher chances of cancer.
The cancer-cholesterol question has been debated since the early 20th century. However, until now, genetic evidence directly linking cholesterol and malignancy has been lacking, said senior study author Hartmut (Hucky) Land, professor and head of biomedical genetics at Rochester, the journal Cell reports.
“Scientifically it is very satisfying to have data that support longstanding ideas about cholesterol in the context of cancer,” Land said. “Our paper provides a rationale for cholesterol targeting as a potentially fruitful approach to cancer intervention or prevention strategies.”
Millions of people take statins, which work by blocking the action of key enzymes in the liver, which synthesizes cholesterol, according to a Rochester statement.
Cholesterol is a fat-like substance in foods and made in cells throughout the body. Too much cholesterol is bad for the heart and vascular system. It is typically measured as serum cholesterol by routine blood tests.
However, unlike serum cholesterol that is bound to proteins, cholesterol also hides inside cells. While locked inside cell membranes before it is eventually exported, cholesterol has an impact on cell growth and survival. A gene, known as ABCA1, is at the crossroads of the process that shuttles intracellular cholesterol outbound.
In the latest investigation, Land and co-author Bradley Smith, post-doctoral fellow in the Land lab, wanted to further understand the role of ABCA1 and cholesterol in cancer. They found that defective cholesterol exportation appears to be a key component in a variety of cancers.
Smith and Land also demonstrated that some of the relatively rare ABCA1 mutations found in human colon cancers by other investigators disabled the gene’s ability to export cholesterol. And by re-establishing the cholesterol export function in human colon cancer cells, they inhibited the cells’ ability to grow as cancers when grafted onto mice.
- Why statins work for some people, but not for all - Apr 22, 2010
- Cholesterol shows promise in fighting cancer - Apr 23, 2012
- Statins can have both beneficial and detrimental on brain cells - Oct 29, 2009
- Blocking rogue gene could halt the spread of most cancers - Jan 25, 2011
- Study suggests being short may protect your from cancer, diabetes - Feb 17, 2011
- Intestinal stem cells offer clues to colon cancer origin and relapse - Mar 18, 2011
- Scientists isolate gene common to unrelated cancers - Jan 02, 2012
- Blocking rogue gene could stop cancer - Jan 25, 2011
- Statin use may cut risk of colorectal cancer - Oct 19, 2010
- Genetic switch that controls tissue regeneration found - Feb 04, 2011
Tags: biomedical genetics, bradley smith, cell membranes, cholesterol, co author, exportation, fruitful approach, genetic evidence, malignancy, medical centre, new discovery, post doctoral fellow, prevention strategies, rochester medical, routine blood tests, serum cholesterol, shuttles, study author, university of rochester, vascular system